✦ LIBER ✦

Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial

✍ Scribed by F. Joseph McClernon; F. Berry Hiott; Eric C. Westman; Jed E. Rose; Edward D. Levin

Publisher: Springer
Year: 2006
Tongue: English
Weight: 192 KB
Volume: 189
Category: Article
ISSN: 0033-3158
DOI: 10.1007/s00213-006-0516-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-blind placebo controlled trial of

Double-blind placebo controlled trial of dextrose tablets and nicotine patch in smoking cessation

✍ R. West; Nicola Willis 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 241 KB

Clinical trial of adjunctive celecoxib t

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

✍ Shahin Akhondzadeh; Sara Jafari; Firoozeh Raisi; Abbas Ali Nasehi; Aboulfazl Gho 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 3 views

A double-blind, placebo-controlled trial

A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: a pilot study

✍ Deborah Deas; Carrie L. Randall; James S. Roberts; Raymond F. Anton 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 3 views

A double-blind placebo controlled trial

A double-blind placebo controlled trial of diltiazem in duchenne dystrophy

✍ Pernice, W. ;Beckmann, R. ;Ketelsen, U.-P. ;Frey, M. ;Schmidt-Redemann, B. ;Haap 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 622 KB

Moclobemide and placebo in mild major de

Moclobemide and placebo in mild major depression: a double-blind randomized trial

✍ E. Ose; P. Holm 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 137 KB

γ-Vinyl GABA: A double-blind placebo-con

γ-Vinyl GABA: A double-blind placebo-controlled trial in partial epilepsy

✍ Dr Lennart Gram; Peter Klosterskov; Mogens Dam 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views

## Abstract The antiepileptic effect of γ‐vinyl γ‐aminobutyric acid (GABA), an irreversible GABA‐transaminase inhibitor, was investigated in an add‐on, placebo‐controlled, double‐blind, cross‐over, fixed‐dose trial. Twenty‐one patients suffering from difficult to control complex partial seizures pa